Mark D. Miller, MD
- 6Articles
- 16.8KReads1
- 1998–2014Active
- 27Collaborators
- 212Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Mark D. Miller, MD, has published extensively on the treatment of depression, anxiety, and related disorders in midlife and older adults. His work includes studies on pharmacological interventions such as buprenorphine, aripiprazole, duloxetine, citalopram, nortriptyline, and paroxetine for late-life depression, anxiety, and traumatic grief. His research has focused on safety, tolerability, and clinical outcomes in geriatric populations, including treatment-resistant depression and suicide risk. Miller's articles appeared in Psychiatrist.com between 1998 and 2014, often collaborating with colleagues such as Charles F. Reynolds III and Benoit H. Mulsant.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
